During the past decade, Lower Manhattan Dialysis Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lower Manhattan Dialysis Center" #1 collaborator was "Davita Clinical Research" with 1 trials as a collaborator, "Frenova Renal Research" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "JMI Laboratories" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Lower Manhattan Dialysis Center" are "Catheter-Related Infections" (1 trials), "Chronic Kidney Disease" (1 trials), "Chronic Kidney Failure" (1 trials), "Chronic Renal Failure" (1 trials) and "Hyperphosphatemia" (1 trials). Many other conditions were trialed in "Lower Manhattan Dialysis Center" in a lesser frequency.

Most popular intervention types in "Lower Manhattan Dialysis Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin Hospira" (1 trials), "Epogen (Amgen)" (1 trials), "Heparin" (1 trials), "Lanthanum carbonate" (1 trials) and "Magnesium iron hydroxycarbonate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lower Manhattan Dialysis Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Lower Manhattan Dialysis Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Lower Manhattan Dialysis Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lower Manhattan Dialysis Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".